Literature DB >> 30005778

Breast Reconstruction.

Hani Sbitany1.   

Abstract

Breast reconstruction is offered to women undergoing mastectomy or breast conservation, given its safe nature and highly aesthetic reconstructive outcomes. Breast implants are safe, offer flexibility of sizes and projections, and shorter recovery. Autologous flaps allow women to avoid prosthetic devices, using skin and fat to replace breast tissue. The increasing frequency of nipple-sparing mastectomy, autologous fat grafting, use of acellular dermal matrices, and prepectoral prosthetic reconstruction have enhanced aesthetic outcomes. Breast conservation outcomes have been enhanced by immediate oncoplastic breast reconstruction to reduce the risks of contour deformities and breast asymmetry, and maintain excellent, oncologically safe, aesthetic outcomes.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acellular dermal matrix; Autologous free flap; Breast implants; Breast reconstruction; Fat grafting; Nipple-sparing mastectomy; Oncoplastic breast surgery

Mesh:

Year:  2018        PMID: 30005778     DOI: 10.1016/j.suc.2018.03.011

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

Review 1.  Direct-to-Implant Subcutaneous Breast Reconstruction: A Systematic Review of Complications and Patient's Quality of Life.

Authors:  José Silva; Francisco Carvalho; Marisa Marques
Journal:  Aesthetic Plast Surg       Date:  2022-09-12       Impact factor: 2.708

2.  Destination Design msTRAM: For Greater Reconstructive Certainty.

Authors:  Stahs Pripotnev; J Scott Williamson
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-07-28

3.  Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol.

Authors:  Lun Li; Benlong Yang; Hongyuan Li; Jian Yin; Feng Jin; Siyuan Han; Ning Liao; Jingping Shi; Rui Ling; Zan Li; Lizhi Ouyang; Xiang Wang; Peifen Fu; Zhong Ouyang; Binlin Ma; Xinhong Wu; Haibo Wang; Jian Liu; Zhimin Shao; Jiong Wu
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.